News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Shattuck Labs (STTK) reported a second-quarter loss per share of 12 cents. Further details regarding their financial performance were not provided in this brief announcement.
This article provides the latest news and social media updates for Astera Labs Inc (Derivatives). It highlights that 12 Nasdaq 100 stocks, including Sandisk, have more than doubled in 2026, with none of them being part of the "Magnificent Seven" group. The article also …
This page provides a comprehensive overview of Astera Labs, Inc. (ALAB) stock, including its current price, historical data, key financial metrics, and analyst insights. The stock closed at $311.99 on August 11, with pre-market trading showing a rise to $318.03. Astera Labs specializes in …
Marvell Technology MRVL and NVIDIA NVDA are collaborating on advanced networking and optical technologies. Their expanded partnership includes silicon photonics and advanced optical interconnect solutions, areas in which MRVL has established capabilities in optical DSPs, silicon photonics and high-speed connectivity, and NVIDIA has NVLink …
Sharemaestro market context Trend signal active 52 weeks +56.7%Shattuck Labs has released an investor deck detailing its strategy to develop DR3-blocking antibodies, primarily SL-325, for inflammatory and immune-mediated diseases. A Phase 2b trial for SL-325 in Crohn's disease is set to begin in Q3 2026, with initial data expected in 1H 2028. …
GeoVax is highlighting its Gedeptin(R) therapy as a tumor-priming strategy following the FDA's accelerated approval of Replimune's intratumoral therapy TUDRIQEV in combination with nivolumab. GeoVax believes this approval reinforces the paradigm that local tumor destruction can enhance immune responses, an area where Gedeptin, a …
Absci Corp. is preparing to announce its second-quarter results, with analysts expecting a significant surge in revenue driven by recent partnership deals, despite a disappointing first quarter. Investors will be closely watching the AI-powered drug discovery company's ability to maintain revenue momentum from its …
As artificial intelligence demands higher performance, investors are weighing the explosive growth of Astera Labs (NASDAQ:ALAB) against the architectural dominance of Arm (NASDAQ:ARM) to find the superior long-term play. While both companies are essential to the modern computing ecosystem, they occupy different niches. Astera …
Sharemaestro market context Trend signal active 52 weeks +56.7%Shattuck Labs (STTK) reported a Q2 2026 net loss of $15.2 million, with $0 revenue, and expects its $208.3 million in cash to fund operations into 2029. The company provided updates on its SL-325 clinical trial, with Phase 2b starting in Q3 2026, and …
* Shattuck Labs press release [https://seekingalpha.com/pr/20614116-shattuck-labs-reports-second-quarter-2026-financial-results-and-recent-business-highlights] (STTK [https://seekingalpha.com/symbol/STTK]): Q2 GAAP EPS of -$0.12 in-line. * As of June 30, 2026, cash and cash equivalents, and short-term investments, were approximately $208.3 million. Shattuck’s current cash and cash equivalents, and short-term investments are expected to fund …
Renaissance Technologies LLC significantly increased its stake in BioAge Labs, Inc. (NASDAQ:BIOA) by 653.2% in the first quarter, acquiring an additional 120,188 shares, bringing its total to 138,588 shares valued at approximately $2.42 million. Other institutional investors also added to their positions. Despite reporting …
This article provides a detailed financial overview of Mobix Labs Inc. Class A (MOBX), including its live share price, performance metrics, historical returns, fundamentals, and peer comparisons. It also outlines how Indian investors can invest in MOBX shares through the INDmoney app, detailing investment …
Assenagon Asset Management S.A. significantly increased its stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 164.9% in the second quarter, now owning 135,897 shares valued at $11.66 million. Other institutional investors also adjusted their positions in the company. Establishment Labs' stock opened at $75.06, …
Shattuck Labs, Inc. has filed its Form 10-Q for the second quarter of 2026 with the SEC, making the report available on August 11, 2026. This filing highlights key risk factors and provides an update on the company's share count. Readers can access the …
Quantum X Labs, the quantum computing arm of Gix Internet, has announced several technical advancements in nuclear simulations, clinical AI, and error correction, leading to significant stock volatility. The company aims to scale its neutral-atom platform to several thousand qubits by the first half …
Jane Street Group, LLC, along with its subsidiaries Jane Street Capital, LLC and Jane Street Global Trading, LLC, has filed an amended Schedule 13G disclosing a 4.3% beneficial ownership in GeoVax Labs, Inc. (GOVX). This stake amounts to 315,275 shares of common stock, with …
Astera Labs director Stefan A. Dyckerhoff sold 12,499 shares of common stock on August 6, 2026, through multiple open-market transactions. These sales were conducted at weighted average prices between $309 and $313 per share, according to a Rule 10b5-1 trading plan established on December …
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; …
Apogee Enterprises Inc. has expanded its board of directors from six to eight members by electing Joseph Hayek and Suresh Krishna as independent directors. Hayek is the president and CEO of Worthington Enterprises Inc., and Krishna is the president and CEO of Proto Labs …
VivoSim Labs (NASDAQ: VIVS) is seeking stockholder approval for several key proposals at its virtual 2026 annual meeting on September 30, 2026. These include electing Class III directors, ratifying their auditor, an advisory vote on executive compensation, and crucially, approving a board-discretionary reverse stock …
Absci Corp (ABSI) is scheduled to release its Q2 2026 earnings on August 11, 2026, with revenue estimates at $1.17 million and earnings at $-0.2 per share. While analyst price targets suggest a significant upside, GuruFocus's GF Value indicates a substantial downside of over …
Establishment Labs Holdings Inc. (NASDAQ:ESTA) saw its stock drop 17% last week after releasing earnings, despite revenues beating expectations by 2.7%. Analysts have updated their forecasts, maintaining revenue estimates but increasing per-share loss expectations, yet they still raised the average price target by 7.1% …
StoneCrest Wealth Management Inc. significantly reduced its stake in Astera Labs (NASDAQ:ALAB) by 91.8% in the second quarter, selling 6,569 shares and retaining 584 shares valued at $282,000. Despite this, institutional investors collectively own 60.47% of ALAB, and the company reported strong Q2 earnings, …
Search by ticker symbol or company name and select a result to open its chart.